(Q51098298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

David J Monsma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

David M Cherba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Patrick J Richardson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sanjeet Rangarajan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dawna Dylewski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Emily Eugster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Stephanie B Scott

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Nicole L Beuschel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Paula J Davidson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Richard Axtell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Deanna Mitchell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Eric P Lester

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Joseph J Junewick

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Craig P Webb

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Noel R Monks

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

31 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

1570-1577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24687871%20AND%20SRC:MED&resulttype=core&format=json

The paradigm of personalized therapy in oncology

12 March 2020

cites work

1 reference

Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology

21 January 2018

1 reference

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

21 January 2018

1 reference

Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics

21 January 2018

1 reference

Cancer pharmacogenomics: early promise, but concerted effort needed

21 January 2018

1 reference

Companion biomarkers: paving the pathway to personalized treatment for cancer

21 January 2018

1 reference

The Intergroup Rhabdomyosarcoma Study-I. A final report

21 January 2018

1 reference

Pharmacotherapy for pediatric soft-tissue sarcomas

21 January 2018

1 reference

A multi-site feasibility study for personalized medicine in canines with osteosarcoma

21 January 2018

1 reference

Finding the tumor copycat: Therapy fails, patients don't

21 January 2018

1 reference

Patient-derived tumour xenografts as models for oncology drug development

21 January 2018

1 reference

Patient-derived tumor xenografts: transforming clinical samples into mouse models

21 January 2018

1 reference

Meeting report: The future of preclinical mouse models in melanoma treatment is now.

21 January 2018

1 reference

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue

21 January 2018

1 reference

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

21 January 2018

1 reference

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer

21 January 2018

1 reference

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

21 January 2018

1 reference

Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group

21 January 2018

1 reference

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

21 January 2018

1 reference

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

21 January 2018

1 reference

Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma

21 January 2018

1 reference

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

Identifying disease-specific genes based on their topological significance in protein networks

21 January 2018

1 reference

Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.

21 January 2018

1 reference

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

21 January 2018

1 reference

Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma

21 January 2018

1 reference

Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas

21 January 2018

1 reference

FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor.

21 January 2018

1 reference

Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer

21 January 2018

1 reference

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

21 January 2018

1 reference

Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells

21 January 2018

1 reference

Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma

21 January 2018

1 reference

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

21 January 2018

1 reference

Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line

21 January 2018

1 reference

Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program

21 January 2018

1 reference

Evolutionary dynamics of cancer in response to targeted combination therapy

21 January 2018

1 reference

Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group

21 January 2018

1 reference

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

21 January 2018

1 reference

Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.

21 January 2018

1 reference

Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.

21 January 2018

1 reference

Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas

21 January 2018

1 reference

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma

21 January 2018

1 reference

Translating gene expression into clinical care: sarcomas as a paradigm

21 January 2018

1 reference